The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial
Abstract
Background The National Institute of Neurological Disorders and Stroke (NINDS) held a workshop on statistical approaches to analysis of acute stroke trials that have multiple prespecified outcomes. An objective was to plan for statistical analysis of the NINDS t-PA Stroke Trial, a randomized, double-blind, placebo-controlled trial of recombinant tissue plasminogen activator (rt-PA) for patients with acute ischemic stroke. Treatment success was defined as a “consistent and persuasive difference” in the proportion of patients achieving favorable outcomes on the Barthel Index, Modified Rankin Scale, Glasgow Outcome Scale, and National Institutes of Health Stroke Scale. The Data and Safety Monitoring Committee for the trial recommended this outcome because the committee did not believe that a positive result for a single outcome would provide sufficient evidence of efficacy. Summary of Comment Workshop participants accepted the global test as a viable approach to testing the primary trial hypothesis. Clinician participants advocated categorizing outcomes as favorable/unfavorable, outcomes more clinically meaningful than continuous outcomes for evaluating a drug with potentially serious side effects. They agreed that a global test was appropriate for ischemic stroke when no single outcome is accepted. Hypothetical, special-case examples illustrate that highly correlated outcomes diminish the power of the global test. NINDS t-PA Stroke Trial data demonstrate the clinical interpretability of the global test. Conclusions Workshop participants concluded that a global statistic should be used to test the trial's primary hypothesis accompanied by secondary tests of individual outcomes. Workshop participants recommended familiarizing the clinical/scientific community with the global approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Mahoney, F. I., & Barthel, D. W. (2013) · PsycTESTS Dataset · doi:10.1037/t02366-000 · Cited by 887
The Analysis of Multiple Endpoints in Clinical Trials
Pocock, S. J., Geller, N. L., & Tsiatis, A. A. (1987) · Biometrics · doi:10.2307/2531989 · Cited by 524
Self-citation
Cited by
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Higashida, R. T., & Furlan, A. J. (2003) · Stroke · doi:10.1161/01.str.0000082721.62796.09 · Cited by 1,543
Clinical interpretation and use of stroke scales
Kasner, S. E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70495-1 · Cited by 934
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Self-citationEffects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Self-citationThe Interventional Management of Stroke (IMS) II Study
The IMS II Trial Investigators (2007) · Stroke · doi:10.1161/strokeaha.107.483131 · Cited by 611
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Lyden, P. D., Lu, M., Levine, S. R., Brott, T. G., & Broderick, J. (2001) · Stroke · doi:10.1161/01.str.32.6.1310 · Cited by 468
Self-citationReliability of the Modified Rankin Scale Across Multiple Raters: Benefits of a Structured Interview
Wilson, J. T. L., Hareendran, A., Hendry, A., Potter, J., Bone, I., & Muir, K. W. (2005) · Stroke · doi:10.1161/01.str.0000157596.13234.95 · Cited by 409
Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
Saver, J. L., Starkman, S., Eckstein, M., Stratton, S. J., Pratt, F. D., Hamilton, S., Conwit, R., Liebeskind, D. S., Sung, G., Kramer, I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408827 · Cited by 407
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15490-1 · Cited by 403
Neuroprotection for ischemic stroke: Two decades of success and failure
Cheng, Y. D., Al-Khoury, L., & Zivin, J. A. (2004) · NeuroRX · doi:10.1602/neurorx.1.1.36 · Cited by 384
Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats
Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., Zhang, L., & Chopp, M. (2002) · Stroke · doi:10.1161/01.str.0000034399.95249.59 · Cited by 383
Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells
Li, Y., Chen, J., Zhang, C. L., Wang, L., Lu, D., Katakowski, M., Gao, Q., Shen, L. H., Zhang, J., Lu, M., et al. (2005) · Glia · doi:10.1002/glia.20126 · Cited by 381
Self-citationLack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
Patel, S. C. (2001) · JAMA · doi:10.1001/jama.286.22.2830 · Cited by 378
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., Lu, M., Raginski, K., Vanguri, P., Smith, A., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600311 · Cited by 353
Self-citationD'Aiuto, F., Parkar, M., Nibali, L., Suvan, J., Lessem, J., & Tonetti, M. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.018 · Cited by 332
Becker, L. B., Aufderheide, T. P., Geocadin, R. G., Callaway, C. W., Lazar, R. M., Donnino, M. W., Nadkarni, V. M., Abella, B. S., Adrie, C., Berg, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182340239 · Cited by 329
Lees, K. R., Asplund, K., Carolei, A., Davis, S. M., Diener, H.-C., Kaste, M., Orgogozo, J.-M., & Whitehead, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02326-6 · Cited by 309
Hill, M. D., Rowley, H. A., Adler, F., Eliasziw, M., Furlan, A., Higashida, R. T., Wechsler, L. R., Roberts, H. C., Dillon, W. P., Fischbein, N. J., et al. (2003) · Stroke · doi:10.1161/01.str.0000082483.37127.d0 · Cited by 283
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Bath, P. M. W., Lees, K. R., Schellinger, P. D., Altman, H., Bland, M., Hogg, C., Howard, G., & Saver, J. L. (2012) · Stroke · doi:10.1161/strokeaha.111.641456 · Cited by 266
Blumenthal, J. A., Sherwood, A., Smith, P. J., Watkins, L., Mabe, S., Kraus, W. E., Ingle, K., Miller, P., & Hinderliter, A. (2016) · Circulation · doi:10.1161/circulationaha.115.018926 · Cited by 257
Giovannoni, G., Cook, S., Rammohan, K., Rieckmann, P., Sørensen, P. S., Vermersch, P., Hamlett, A., Viglietta, V., & Greenberg, S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70023-0 · Cited by 252
Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure
Lees, K. R., Bath, P. M. W., Schellinger, P. D., Kerr, D. M., Fulton, R., Hacke, W., Matchar, D., Sehra, R., & Toni, D. (2012) · Stroke · doi:10.1161/strokeaha.111.641423 · Cited by 242
Hacke, W., Bluhmki, E., Steiner, T., Tatlisumak, T., Mahagne, M.-H., Sacchetti, M.-L., & Meier, D. (1998) · Stroke · doi:10.1161/01.str.29.10.2073 · Cited by 109
Minocycline development for acute ischemic stroke
Fagan, S. C., Cronic, L. E., & Hess, D. C. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0072-6 · Cited by 100
Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
Tang, D., & Geller, N. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01188.x · Cited by 81
Self-citationWeir, C. J., Kaste, M., & Lees, K. R. (2004) · Stroke · doi:10.1161/01.str.0000136556.34438.b3 · Cited by 31
Neuroprotection: Lessons from a Spectrum of Neurological Disorders
Galpern, W. R., & Singhal, A. B. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00023.x · Cited by 4
Metadata
- Authors
- Tilley, B. C., Marler, J., Geller, N. L., Lu, M., Legler, J., Brott, T., Lyden, P., & Grotta, J.
- Venue
- Stroke
- Published
- 1996-11
- Volume
- 27
- Issue
- 11
- Pages
- 2136-2142
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1964052017
- Cited by
- 229
- References
- 5
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.